| Literature DB >> 27149274 |
Jeff Ching-Fu Hsieh1, Susanna M Cramb2, James M McGree1, Nathan A M Dunn3, Peter D Baade2, Kerrie L Mengersen1.
Abstract
An increasing number of studies have identified spatial differences in breast cancer survival. However little is known about whether the structure and dynamics of this spatial inequality are consistent across a region. This study aims to evaluate the spatially varying nature of predictors of spatial inequality in relative survival for women diagnosed with breast cancer across Queensland, Australia. All Queensland women aged less than 90 years diagnosed with invasive breast cancer from 1997 to 2007 and followed up to the end of 2008 were extracted from linked Queensland Cancer Registry and BreastScreen Queensland data. Bayesian relative survival models were fitted using various model structures (a spatial regression model, a varying coefficient model and a finite mixture of regressions model) to evaluate the relative excess risk of breast cancer, with the use of Markov chain Monte Carlo computation. The spatially varying coefficient models revealed that some covariate effects may not be constant across the geographic regions of the study. The overall spatial patterns showed lower survival among women living in more remote areas, and higher survival among the urbanised south-east corner. Notwithstanding this, the spatial survival pattern for younger women contrasted with that for older women as well as single women. This complex spatial interplay may be indicative of different factors impacting on survival patterns for these women.Entities:
Mesh:
Year: 2016 PMID: 27149274 PMCID: PMC4857928 DOI: 10.1371/journal.pone.0155086
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Posterior estimates of relative excess risk (RER) of mortality across Queensland, 1997–2008.
| Median RER [95% CrI | |||||
|---|---|---|---|---|---|
| Spatial Regression | Varying Coefficient | Finite Mixture | |||
| Factors | N | Median RER | VC range | Cluster P | |
| <40 | 1428 | 0.90 [0.77, 1.06] | 0.84 [0.70, 1.01] | [0.520, 1.66] | 0.90 [0.77, 1.06] |
| 40–49 | 4669 | 0.82 [0.72, 0.93] | 0.83 [0.71, 0.95] | [0.601, 2.10] | 0.82 [0.72, 0.93] |
| 50–59 | 6443 | 1.00 | 1.00 | — | 1.00 |
| 60–69 | 5545 | 1.12 [0.98, 1.27] | 1.11 [0.95, 1.28] | [0.636, 1.46] | 1.12 [0.98, 1.27] |
| 70–89 | 5681 | 1.46 [1.29, 1.66] | 1.45 [1.25, 1.68] | [0.652, 1.40] | 1.47 [1.30, 1.66] |
| Indigenous | 257 | 1.83 [1.40, 2.37] | 1.63 [1.12, 2.32] | [0.718, 1.72] | 1.83 [1.39, 2.36] |
| Non-Indigenous | 20529 | 1.00 | 1.00 | — | 1.00 |
| Unknown | 2980 | 0.03 [0.01, 0.07] | 0.02 [0.01, 0.05] | [0.731, 1.74] | 0.03 [0.01, 0.07] |
| Has partner | 14801 | 1.00 | 1.00 | — | 1.00 |
| Single | 1441 | 1.25 [1.07, 1.46] | 1.29 [1.08, 1.56] | [0.594, 1.79] | 1.26 [1.07, 1.46] |
| Widowed/Divorced/Separated | 6787 | 1.38 [1.25, 1.51] | 1.38 [1.24, 1.54] | [0.739, 1.36] | 1.38 [1.26, 1.51] |
| Unknown | 737 | 0.38 [0.16, 0.70] | 0.19 [0.03, 0.52] | [0.220, 21.75] | 0.38 [0.17, 0.69] |
| Localised (Stage I) | 11517 | 1.00 | 1.00 | — | 1.00 |
| Advanced (Stage II, III, IV) | 10699 | 4.23 [3.70, 4.87] | 4.23 [3.68, 4.91] | [0.798, 1.25] | 4.23 [3.71, 4.85] |
| Unknown | 1581 | 14.03 [12.26, 16.77] | 14.53 [12.35, 17.20] | [0.690, 3.00] | 14.29 [12.32, 16.66] |
| Yes | 9745 | 1.00 | 1.00 | — | 1.00 |
| No | 14052 | 1.91 [1.71, 2.12] | 1.96 [1.74, 2.21] | [0.927, 1.06] | 1.92 [1.72, 2.14] |
| 34797 | 34795 | 34861 | |||
| 113 | 345 | 177 | |||
| 98.61% | 98.64% | 99.99% | |||
Abbreviations: CrI = Credible interval, N = Number of patients, DIC = Deviance information criterion, pD = Effective number of parameters, PPC = posterior predictive check.
Exponentiated median varying coefficient (VC) values (exp(δ)) of 478 SLA.
Mixing probability of SLA been allocate in the cluster.
Model reduction comparison.
| Varying coefficient | Finite Mixture | |
|---|---|---|
| DIC | 34795 | 34861 |
| pD | 345 | 177 |
| DIC | 34814 | — |
| pD | 335 | — |
| DIC | — | 34823 |
| pD | — | 36 |
Abbreviations: DIC = Deviance information criterion, pD = Effective number of parameters.
Fig 1SLA-specific relative excess risk (RER) (exp(u + v)) map for the varying coefficient model.
Fig 2Relative spatially varying coefficient (RSVC = exp(δ + u + v)) effect maps for the age at diagnosis and Indigenous status variables.
Fig 3Relative spatially varying coefficient (RSVC = exp(δ + u + v)) effect maps for the partner status, tumour stage and BSQ participant variables.